Restricted accessResearch articleFirst published online 2024-10
Comparison of the effect of uric acid/albumin ratio on coronary colleteral circulation with other inflammation-based markers in stable coronary artery disease patients
The Uric acid/Albumin ratio (UAR) has recently been identified as a prominent marker in cardiovascular diseases. In this study, we aimed to reveal the effect of UAR on coronary collateral circulation (CCC) in patients with stable coronary artery disease (CAD) patients by comparing it with conventional inflammation-based markers.
Methods
In this study, 415 consecutive patients who underwent coronary angiography for stable angina pectoris and were found to have chronic total occlusion in at least one coronary artery were retrospectively included. The study population was divided into two groups as good CCC (Rentrop 2–3) and poor CCC (Rentrop 0–1) according to the Rentrop classification, and the groups were compared in terms of UAR and other traditional inflammation-based markers.
Results
In the poor CCC group, C-reactive protein/albumin ratio (CAR), monocyte/high-density lipoprotein cholesterol ratio (MHR), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), systemic immune-inflammation index (SII) and UAR were found to be significantly high (p < .05, for all). UAR negatively correlated with rentrop classification (r = −0.383, p < .001). In multivariate regression analysis, MHR, NLR, SII and UAR were determined as independent predictors for poor CCC (p < .05, for all). The ability of UAR to predict poor CCC was superior to uric acid and albumin alone (p < .0001, for both). In addition, UAR was found to be superior to other inflammation-based markers in predicting poor CCC (p < .005, for all).
Conclusion
UAR was identified as a strong and independent predictor of CCC. In this context, UAR may be a useful biomarker in the risk prediction of patients with stable CAD.
FujitaMTambaraK. Recent insights into human coronary collateral development. Heart2004; 90: 246–250.
2.
RegieliJJNathoeHMKoerselmanJ, et al.Coronary collaterals--insights in molecular determinants and prognostic relevance. Int J Cardiol2007; 116: 139–143.
3.
SeilerCStollerMPittB, et al.The human coronary collateral circulation: development and clinical importance. Eur Heart J2013; 34: 2674–2682.
4.
CohenMRentropKP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation1986; 74: 469–476.
5.
CarmelietP. Mechanisms of angiogenesis and arteriogenesis. Nat Med2000; 6: 389–395.
6.
FujitaMOhnoAWadaO, et al.Collateral circulation as a marker of the presence of viable myocardium in patients with recent myocardial infarction. Am Heart J1991; 122: 409–414.
7.
RisauWZerwesHG. Role of growth factors in the formation of blood vessels. Z Kardiol1989; 78(Suppl 6): 9–11.
8.
ChertokVMChertokAGZenkinaVG. Endotelıal-dependent of the regulation of angiogenesis. Tsitologiia2017; 59: 243–258.
9.
BuschmannISchaperW. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol2000; 190: 338–342.
10.
van RoyenNPiekJJBuschmannI, et al.Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res2001; 49: 543–553.
11.
KernerAGrubergLGoldbergA, et al.Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am J Cardiol2007; 99: 509–512.
12.
AkbogaMKYalcinRSahinarslanA, et al.Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol2016; 224: 323–327.
13.
KelesogluSYilmazYElcıkD, et al.Systemic immune inflammation index: a novel predictor for coronary collateral circulation. Perfusion2022; 37: 605–612.
14.
AdaliMKBuberISenG, et al.Relationship between systemic immune-inflammation index and coronary collateral circulation in patients with chronic total occlusion. Arq Bras Cardiol2022; 119: 69–75.
15.
GokMKundiHKiziltuncE, et al.Endocan levels and coronary collateral circulation in stable angina pectoris: a pilot study. Angiology2018; 69: 43–48.
16.
KelesogluSYilmazYElcıkD. Relationship between c-reactive protein to albumin ratio and coronary collateral circulation in patients with stable coronary artery disease. Angiology2021; 72(9): 829–835.
17.
BaltaSDemirkolSKucukU, et al.The relationship between neutrophil-lymphocyte ratio and coronary collateral circulation. Perfusion2014; 29: 367–368.
18.
LiSChenHZhouL, et al.The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention. Scand J Clin Lab Invest2022; 82: 304–310.
19.
ZhangYXuZHeW, et al.Elevated serum uric acid/albumin ratio as a predictor of post-contrast acute kidney injury after percutaneous coronary intervention in patients with st-segment elevation myocardial infarction. J Inflamm Res2022; 15: 5361–5371.
20.
UysalOKSahinDYDuranM, et al.Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology2014; 65: 227–231.
21.
DuranMOrnekEMuratSN, et al.High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology2012; 63(6): 472–475.
22.
BelinskaiaDAVoroninaPAShmurakVI, et al.Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties. Int J Mol Sci2021; 22: 10318.
23.
SitarMEAydinSCakatayU. Human serum albumin and its relation with oxidative stress. Clin Lab2013; 59: 945–952.
24.
ArquesS. Human serum albumin in cardiovascular diseases. Eur J Intern Med2018; 52: 8–12.
25.
ZhaoYWangSYangJ, et al.Association of fibrinogen/albumin ratio and coronary collateral circulation in stable coronary artery disease patients. Biomark Med2020; 14: 1513–1520.
26.
AmbrosioGMugelliALopez-SendónJ, et al.Management of stable angina: a commentary on the European Society of Cardiology guidelines. Eur J Prev Cardiol2016; 23: 1401–1412.
27.
RentropKPThorntonJCFeitF, et al.Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol1988; 61: 677–684.
28.
RentropKPCohenMBlankeH, et al.Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol1985; 5: 587–592.
29.
MontalescotGSechtemUAchenbachS, et al.ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the european society of cardiology. Eur Heart J2013; 34: 2949–3003.
30.
RamanathanKBWilsonJLIngramLA, et al.Effects of immature recruitable collaterals on myocardial blood flow and infarct size after acute coronary occlusion. J Lab Clin Med1995; 125: 66–71.
31.
MarzulloAAmbrosiFInchingoloM, et al.ST2L transmembrane receptor expression: an immunochemical study on endarterectomy samples. PLoS One2016; 11(5): e0156315.
32.
ScicchitanoPMarzulloASantoroA, et al.The prognostic role of ST2L and sST2 in patients who underwent carotid plaque endarterectomy: a five-year follow-up study. J Clin Med2022; 11(11): 3142.
33.
ChoiYSChoiHJMinJK, et al.Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood2009; 114(14): 3117–3126.
34.
KerstenJRTollerWGTessmerJP, et al.Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol2001; 281: H2097–H2104.
35.
BadimonLPeñaEArderiuG, et al.C-reactive protein in atherothrombosis and angiogenesis. Front Immunol2018; 9: 430.
36.
PeluzzoAMAutieriMV. Challenging the paradigm: anti-inflammatory interleukins and angiogenesis. Cells2022; 11: 587.
KasapkaraHATopsakalRYarliogluesM, et al.Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis2012; 23: 421–425.
39.
WangCSSunYRenJ. Uric acid to albumin ratio, a novel biomarker of cardiovascular disease. Angiology2023; 33197231178888.
40.
MuroharaTAsaharaT. Nitric oxide and angiogenesis in cardiovascular disease. Antioxid Redox Signal2002; 4: 825–831.
41.
PapežíkováIPekarováMKolářováH, et al.Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res2013; 47: 82–88.
42.
ZouXChenMSunL, et al.Hyperinsulinemia impaired coronary collateral circulation in patients with chronic total coronary occlusion. Diabetes Metab Syndr Obes2023; 16: 1425–1433.
43.
ChoiYJYoonYLeeKY, et al.Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J2014; 28: 3197–3204.
44.
YuSHongQWangY, et al.High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a. Circ J2015; 79: 2487–2498.
45.
BörekçiAGürMŞekerT, et al.Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score. Perfusion2015; 30: 457–464.
46.
KimuraYTsukuiDKonoH. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int J Mol Sci2021; 22: 12394.
47.
ÇakmakEÖBayamEÇelikM, et al.Uric acid-to-albumin ratio: a novel marker for the extent of coronary artery disease in patients with non-st-elevated myocardial infarction. Pulse (Basel)2021; 8(3–4): 99–107. Epub 2021 Mar 4. PMID: 34307206; PMCID: PMC8280454. DOI: 10.1159/000514533.
BaykanAOGürMAceleA, et al.Coronary collateral development and arterial stiffness in patients with chronic coronary total occlusions. Scand Cardiovasc J2015; 49: 228–234.
